Alex Gorsky to be Johnson & Johnson’s new CEO After Weldon

Alex Gorsky

Alex Gorsky

Johnson & Johnson has picked up a new CEO, to succeed Bill Weldon after his retirement in April this year. The healthcare giant J&J said its decade-old Chief Executive Officer William Weldon will step down from his post in April. To succeed him is the vice chairman Alex Gorsky, as the ninth chief executive officer of the 126 year-old company, while Weldon, aged 63, remains the chairman of the board.

Bill Weldon, who has served as CEO of Johnson & Johnson since 2002 and will remain on the company’s board of directors as chairman, said in a statement given to a business magazine that the selection process for his successor was thorough.

Weldon said, “This succession decision involved a rigorous, thorough and formal multi-year process, which included consideration of two superbly qualified internal candidates, as well as outside candidates. The future of J& J is in very capable hands.”

Several manufacturing magazines report that Gorsky, aged 51, is currently vice chairman of the company’s executive committee with responsibility for the Medical Devices & Diagnostics Group, Global Supply Chain, Health Care Compliance & Privacy and Government Affairs & Policy.

Gorksy’s appointment is effective April 26, 2012, the date of the healthcare giant J&J’s annual meeting of shareholders. He was also nominated for election to the board of directors at the annual meeting.

Weldon and the product recalls

Most likely, the news agencies must be focusing the stories of the announcement of the new CEO on the product recalls that have dogged the company for the past few years. But that seems a bit unfair, for Bill Weldon deserves credit for a lot of good management over his decade-plus near the top of one of the world’s biggest health care companies, and the consumer products debacle shouldn’t even rank among his worst foul-ups.

Over Weldon’s ten-year reign, J&J experienced its shares outperforming Pfizer, Merck, GlaxoSmithKline, and even Abbott Laboratories. The healthcare giant J&J also launched more drugs than its rivals – 11 during his term as chief executive and three more during his time as head of the pharmaceuticals business, between 1998 and 2002.

Gorsky’s time spend in J&J

Alex Gorsky first joined Johnson & Johnson as a sales representative for Janssen Pharmaceutica. Gorksy had advanced his way to become the president of Janssen by 2001.  In 2003, Alex Gorsky was promoted to oversee Johnson & Johnson’s pharmaceutical business in Europe, the Middle East and Africa. Thereafter he left J&J in 2004 and returned back after four years as head of pharmaceuticals in North America at Novartis. Gorsky was appointed as worldwide chairman of the surgical care group as well as the company’s executive committee, in 2009.

Erik Gordon, a business professor at the University of Michigan, in Ann Arbor said, “Gorsky is a conservative choice and the strongest internal candidate. That’s a big deal at a company that always taps an insider as its next CEO, even if what they need is someone from outside the team that led the company into so much trouble.”

 

Aubrey Chang
Aubrey Chang, Associate Editor Industry Leaders Magazine (www.industryleadersmagazine.com)

Recent Posts

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

A report by blockchain data platform Chainalysis reveals that nearly $14 billion in cryptocurrency were sent to illicit addresses in 2021.
12 hours ago
Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Musk had previously revealed that he hopes the company will be able to address a wide range of neurological problems – ranging from addiction to paralysis.
1 day ago
Winter Olympics 2022: The Silence of the Brands

Winter Olympics 2022: The Silence of the Brands

Brands see the Olympics as an opportunity to connect with their consumers and boost sales with limited edition products.
2 days ago
Best Fintech Stocks to Buy in 2022

Best Fintech Stocks to Buy in 2022

The biggest names on Wall Street are buying some of these best fintech stocks of the year. Now maybe a great chance to invest money in the right business.
2 days ago
The Untold Story of How Elon Musk Ousted Tesla’s Founders

The Untold Story of How Elon Musk Ousted Tesla’s Founders

Not many know that Tesla wasn’t founded by Elon Musk. So who founded the world’s most valuable automotive company?
3 days ago
What’s the new inflation rate saying?

What’s the new inflation rate saying?

According to the US consumer price index, the inflation rate has witnessed a rapid rise during the past six months since it’s 0.8% increase in November.
3 days ago